iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Sold by Arkansas Financial Group Inc.

Arkansas Financial Group Inc. cut its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 20.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 6,923 shares of the company’s stock after selling 1,746 shares during the quarter. Arkansas Financial Group Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $455,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. US Bancorp DE raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after purchasing an additional 222 shares in the last quarter. Assetmark Inc. increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after buying an additional 216 shares in the last quarter. Allworth Financial LP lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 9.4% during the 3rd quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock valued at $131,000 after acquiring an additional 159 shares during the last quarter. EP Wealth Advisors LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter worth $157,000. Finally, Farther Finance Advisors LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 97.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,482 shares of the company’s stock worth $175,000 after acquiring an additional 1,223 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Up 1.3 %

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $67.59 on Friday. iShares U.S. Pharmaceuticals ETF has a 12-month low of $62.67 and a 12-month high of $72.94. The firm has a market capitalization of $682.66 million, a PE ratio of 6.49 and a beta of 0.58. The stock’s fifty day moving average is $67.05 and its 200-day moving average is $69.00.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.